Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medspira is a private U.S. medical device company focused on anorectal diagnostics and pelvic floor biofeedback therapy. Its core commercial product is the mcompass system, a portable FDA-cleared device used for anorectal manometry and manometric biofeedback in office-based and clinic settings. The company positions its technology as a compact, easy-to-use alternative to traditional anorectal physiology systems, with disposable catheter-based testing and therapy workflows. Medspira serves gastroenterology, colorectal, pelvic floor, and related care settings, with commercialization focused in the United States. The business appears to be a commercial-stage medtech company rather than a therapeutics developer, with revenue derived from device sales and related consumables/support rather than a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medspira.